Skip to main content

Table 1 Baseline characteristics of the study population

From: Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial

Variables

Study group (n = 76)

Control group (n = 93)

p-value

Demographic characteristics

Age (years), mean ± SD

32.50 ± 3.30

31.92 ± 3.68

0.29

BMI (kg/m2), mean ± SD

21.85 ± 2.51

22.24 ± 3.07

0.37

Infertility duration (years), median (IQR)

3 (2, 4)

3 (2, 3)

0.32

Primary infertility, n (%)

48/76 (63.15)

65/93 (69.89)

0.71

Nulliparity, n (%)

72/76 (94.74)

86/93 (92.47)

0.76

Previous ART treatments, n (%)

11/76 (14.47)

20/93 (21.51)

0.43

Ovarian reserve markers

AMH (ng/ml), median (IQR)

0.57 (0.35, 0.80)

0.56 (0.35, 0.80)

0.46

AFC, median (IQR)

5 (3, 6)

4 (3, 6)

0.17

Day 3 FSH (IU/ml), median (IQR)

12.25 (9.39, 15.50)

12.6 (9.95, 15.60)

0.58

Diagnosis of infertility in addition to POR

Tubal factor, n (%)

13/76 (17.11)

22/93 (23.66)

0.61

Male factor, n (%)

22/76 (28.95)

25/93 (26.88)

0.82

Unexplained, n (%)

22/76 (28.95)

25/93 (26.88)

0.82

  1. AMH - anti-Mullerian hormone; AFC - antral follicle count; BMI – body mass index; IQR – interquartile range; POR – poor ovarian reserve; SD – standard deviation